HomeMEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES

MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES

Orange Biomed Launches in U.S. Market to Reduce Inaccuracies in Diabetes Diagnosis for Minorities and Help Manage Diabetes at Home with a Revolutionary POC...

Park continued, "OBM rapid A1c is a portable, guided, five-minute test requiring only a single drop of blood to produce accurate results. By seamlessly integrating lab-level technology into portable devices, we seek to make healthcare more accessible, accurate, and affordable for everyone."

Sonitor Introduces SonitorBLU™ and SonitorMOBILE™

“Sonitor is excited to invite healthcare providers, technology partners and all HIMSS attendees to our booth where we will be showcasing the SonitorBLU, Sonitor Sense and SonitorMOBILE suite of products,” said Matt Crane, Chief Commercial Officer, North America/CEO, Sonitor Inc. “In addition, we have recently expanded our team of clinical and technology experts to customize Sonitor’s solutions to meet customers’ strategic objectives and budgets.”

Rexton Launches BiCore B-Li M Rugged – the Most Resilient Behind-the-Ear Hearing Aid

According to Rexton Product Manager Katie Stocker, the new BiCore B-Li M Rugged is ideal for full-time patient use, matching the company’s reliable audio quality with significant durability enhancements and a smaller, more discrete size that improves comfort and aesthetics.

PreOmics Introduces a Novel BeatBox™ FFPE Workflow for Accelerated, In-depth Tissue Proteomics

Introduction of a FFPE workflow extends the tissue proteomics applications of PreOmics’ unique BeatBox™ technology.

Biomerics Expands Manufacturing Operations In Texas

Biomerics 24,000 sq. ft. expansion is located in their Athens, TX, facility.

Essex Bio-Technology and Osteopore Entered Into Exclusive Distribution Agreement for Oral Maxillofacial Products in Singapore

Pursuant to the Distribution Agreement, Majeton will be the exclusive distributor of the Products for an initial period of 3 years, starting from 2023 to 2026. notes Essex Bio-Technology.

Glytec Unveils the Next Evolution of GlucoMetricsⓇ, Giving Hospital Leaders New Insights and Analytics to Improve Glycemic Management and Readiness for New CMS Measures

“CMS is making it clear that hypoglycemia related to insulin is largely preventable, and early treatment and optimal management of severe hyperglycemia is a priority. But it’s hard to enact and measure this type of change without access to data, or the expertise to turn that data into actionable insights,” said Jordan Messler, MD, Chief Medical Officer at Glytec.

RAIsonance, Inc. Announces BARDA Contract to Continue Development of the AudibleHealth Dx Diagnostic SaMD for COVID-19 and Influenza Through AI-Powered Cough Analysis

The contract consists of just over $749,000 allocated to the continued development of RAIsonance’s AudibleHealth Dx Diagnostic SaMD. The device is designed to analyze a user’s Forced Cough Vocalization (FCV) in the diagnosis of illness, with the current focus on both COVID-19 and Influenza.

Tivic Expands Bioelectronic Portfolio; Files Patent Application for New Approach to Non-Invasive Vagus Nerve Stimulation

Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that it has...
Exit mobile version